Display options
Cite
Panchal SS, Patidar RK, Jha AB, et al. Anti-Inflammatory and Antioxidative Stress Effects of Oryzanol in Glaucomatous Rabbits. J Ophthalmol. 2017;2017:1468716doi: 10.1155/2017/1468716.
Panchal, S. S., Patidar, R. K., Jha, A. B., Allam, A. A., Ajarem, J., & Butani, S. B. (2017). Anti-Inflammatory and Antioxidative Stress Effects of Oryzanol in Glaucomatous Rabbits. Journal of ophthalmology, 20171468716. https://doi.org/10.1155/2017/1468716
Panchal, Shital S, et al. "Anti-Inflammatory and Antioxidative Stress Effects of Oryzanol in Glaucomatous Rabbits." Journal of ophthalmology vol. 2017 (2017): 1468716. doi: https://doi.org/10.1155/2017/1468716
Panchal SS, Patidar RK, Jha AB, Allam AA, Ajarem J, Butani SB. Anti-Inflammatory and Antioxidative Stress Effects of Oryzanol in Glaucomatous Rabbits. J Ophthalmol. 2017;2017:1468716. doi: 10.1155/2017/1468716. Epub 2017 Jan 12. PMID: 28168044; PMCID: PMC5266835.
Copy Download .nbib Format: NLM
Share it on

J Ophthalmol. 2017;2017:1468716. doi: 10.1155/2017/1468716. Epub 2017 Jan 12.

Anti-Inflammatory and Antioxidative Stress Effects of Oryzanol in Glaucomatous Rabbits.

Journal of ophthalmology

Shital S Panchal, Rajesh K Patidar, Abhishek B Jha, Ahmed A Allam, Jamaan Ajarem, Shital B Butani

Affiliations

  1. Institute of Pharmacy, Nirma University, Sarkhej-Gandhinagar Highway, Ahmedabad 382481, India.
  2. Department of Zoology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia; Department of Zoology, Faculty of Science, Beni-Suef University, Beni-Suef 62511, Egypt; Nahda University in Beni Suef, Beni-Suef 62511, Egypt.
  3. Department of Zoology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.

PMID: 28168044 PMCID: PMC5266835 DOI: 10.1155/2017/1468716

[No abstract available.]

Conflict of interest statement

The authors declare that there is no conflict of interests regarding the publication of this paper.

References

  1. Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9455-6 - PubMed
  2. Br J Ophthalmol. 2001 Oct;85(10):1252-9 - PubMed
  3. J Biol Chem. 1951 Nov;193(1):265-75 - PubMed
  4. Invest Ophthalmol Vis Sci. 2005 Jan;46(1):175-82 - PubMed
  5. J Neurochem. 2005 Feb;92(4):749-58 - PubMed
  6. Int J Pharm. 2005 Aug 11;299(1-2):146-54 - PubMed
  7. Ophthalmol Clin North Am. 2005 Sep;18(3):383-95, vi - PubMed
  8. Physiol Res. 2007;56(1):105-12 - PubMed
  9. J Clin Biochem Nutr. 2007 Mar;40(2):92-100 - PubMed
  10. Invest Ophthalmol Vis Sci. 2008 Feb;49(2):622-8 - PubMed
  11. Brain Res. 2008 May 13;1209:136-50 - PubMed
  12. Br J Pharmacol. 2008 Jun;154(4):812-24 - PubMed
  13. Prog Brain Res. 2008;173:409-21 - PubMed
  14. Mediators Inflamm. 2010;2010:939602 - PubMed
  15. Curr Top Med Chem. 2011;11(14):1847-53 - PubMed
  16. Invest Ophthalmol Vis Sci. 2011 Oct 31;52(11):8442-54 - PubMed
  17. J Ocul Pharmacol Ther. 2012 Oct;28(5):459-66 - PubMed
  18. J Neuroinflammation. 2012 Sep 10;9:213 - PubMed
  19. EPMA J. 2010 Jun;1(2):229-35 - PubMed
  20. Int J Colorectal Dis. 2014 Feb;29(2):267-9 - PubMed
  21. J Ocul Biol. 2013 Jun;1(1):3 - PubMed
  22. BMC Complement Altern Med. 2014 Dec 05;14:467 - PubMed
  23. Taiwan J Ophthalmol. 2016 Jul-Sep;6(3):131-135 - PubMed
  24. Anal Biochem. 1979 Jun;95(2):351-8 - PubMed
  25. Cancer Res. 1984 Nov;44(11):5086-91 - PubMed
  26. J Pharmacol Exp Ther. 1995 Mar;272(3):1011-5 - PubMed

Publication Types